Replies to post #210170 on Biotech Values

[DewDiligence]

ADXS—More on phase-1 data in second-line cervical
cancer…

Poster presentation:
http://www.advaxis.com/wp-content/uploads/2015/11/High-dose-treatment-with-ADXS11-001.pdf

Feature story on one patient in the Augusta (GA) Chronicle:
http://chronicle.augusta.com/news/2017-03-22/clinical-trial-underway-au-cervical-cancer-vaccine-0